Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2014 (2014), Article ID 354687, 4 pages
http://dx.doi.org/10.1155/2014/354687
Case Report

Giant Malignant Pheochromocytoma with Palpable Rib Metastases

1Department of Urology, Cumhuriyet University Medical Faculty, 58140 Sivas, Turkey
2Department of Endocrinology, Cumhuriyet University Medical Faculty, 58140 Sivas, Turkey
3Department of Pathology, Cumhuriyet University Medical Faculty, 58140 Sivas, Turkey

Received 7 April 2014; Revised 24 June 2014; Accepted 21 July 2014; Published 3 August 2014

Academic Editor: Christian Pavlovich

Copyright © 2014 Esat Korgali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Zarnegar, E. Kebebew, Q. Duh, and O. H. Clark, “Malignant Pheochromocytoma,” Surgical Oncology Clinics of North America, vol. 15, no. 3, pp. 555–571, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ayala-Ramirez, L. Feng, M. M. Johnson, S. Ejaz, M. A. Habra, and T. Rich, “Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 3, pp. 717–725, 2011. View at Google Scholar
  3. L. D. Thompson, W. F. Young, A. Kawashima, P. Komminoth, and A. S. Tischler, “Malignant adrenal phaeochromocytoma,” in WHO Classification of Tumors: Pathology and Geneticstumors of Endocrine Organs, R. A. DeLellis, R. V. Lloyd, P. U. Heitz, and C. Eng, Eds., pp. 147–150, IARC, Lyon, France, 2004. View at Google Scholar
  4. J. M. Rodríguez González, P. Parrilla Paricio, and A. Piñero Madrona, “Feocromocitoma,” in Cirugía Endocrina, A. Sitges-Serra and J. Sancho Insenser, Eds., pp. 143–150, Aran, Madrid, Spain, 1999. View at Google Scholar
  5. R. E. Goldstein, J. A. O'Neill Jr., G. W. Holcomb III et al., “Clinical experience over 48 years with pheochromocytoma,” Annals of Surgery, vol. 229, no. 6, pp. 755–766, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Adjallé, P. F. Plouin, K. Pacak, and H. Lehnert, “Treatment of malignant pheochromocytoma,” Hormone and Metabolic Research, vol. 41, no. 9, pp. 687–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ayala-Ramirez, J. L. Palmer, M. Hofmann et al., “Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 4, pp. 1492–1497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Eisenhofer, G. Rivers, A. L. Rosas, Z. Quezado, W. M. Manger, and K. Pacak, “Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management,” Drug Safety, vol. 30, no. 11, pp. 1031–1062, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Jimenez, E. Rohren, M. A. Habra et al., “Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma,” Current Oncology Reports, vol. 15, no. 4, pp. 356–371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Mannelli, “Management and treatment of pheochromocytomas and paragangliomas,” Annals of the New York Academy of Sciences, vol. 1073, pp. 405–416, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ayala-Ramirez, C. N. Chougnet, M. A. Habra et al., “Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 11, pp. 4040–4050, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Ayala-Ramirez, L. Feng, M. A. Habra et al., “Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience,” Cancer, vol. 118, no. 11, pp. 2804–2812, 2012. View at Publisher · View at Google Scholar · View at Scopus